Veterinary Medicines

Covexin 8 suspensão injetável para ovinos e bovinos

Authorised
  • Clostridium perfringens, type B and C, beta toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium chauvoei, Inactivated
  • Clostridium novyi, toxoid
  • Clostridium novyi, toxoid
  • Clostridium septicum, toxoid
  • Clostridium tetani, toxoid
Download as PDF

Product identification

Medicine name:
Covexin 8 suspensão injetável para ovinos e bovinos
Active substance:
  • Clostridium perfringens, type B and C, beta toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium chauvoei, Inactivated
  • Clostridium novyi, toxoid
  • Clostridium novyi, toxoid
  • Clostridium septicum, toxoid
  • Clostridium tetani, toxoid
Target species:
  • Cattle
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium perfringens, type B and C, beta toxoid
    10.00
    international unit(s)
    /
    5.00
    millilitre(s)
  • Clostridium perfringens, type D, epsilon toxoid
    5.00
    international unit(s)
    /
    5.00
    millilitre(s)
  • Clostridium chauvoei, Inactivated
    1.00
    European Pharmacopoeia Unit(s)
    /
    5.00
    millilitre(s)
  • Clostridium novyi, toxoid
    10.00
    international unit(s)
    /
    5.00
    millilitre(s)
  • Clostridium novyi, toxoid
    3.50
    international unit(s)
    /
    5.00
    millilitre(s)
  • Clostridium septicum, toxoid
    2.50
    international unit(s)
    /
    5.00
    millilitre(s)
  • Clostridium tetani, toxoid
    2.50
    international unit(s)
    /
    5.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI04AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 8(3) of Directive No 2001/83/EC)
Marketing authorisation holder:
  • Zoetis Portugal Lda.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Gmax Biopharm Belgium
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 168/87
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 15/06/2023
Updated on: 18/06/2023
Download